Does physiological β cell turnover initiate autoimmune diabetes in the regional lymph nodes?

被引:18
作者
Pearl-Yafe, Michal
Iskovich, Svetlana
Kaminitz, Ayelet
Stein, Jerry
Yaniv, Isaac
Askenasy, Nadir
机构
[1] Schneider Childrens Med Ctr Israel, Ctr Stem Cell Res, Frankel Lab, IL-49202 Petah Tiqwa, Israel
[2] Schneider Childrens Med Ctr Israel, Bone Marrow Transplantat Unit, IL-49202 Petah Tiqwa, Israel
[3] Schneider Childrens Med Ctr Israel, Dept Pediat Hematol Oncol, IL-49202 Petah Tiqwa, Israel
关键词
autoimmune diabetes; pancreatic lymph nodes; beta cell turnover; regulatory antigen presenting cells;
D O I
10.1016/j.autrev.2006.02.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The initial immune process that triggers autoimmune beta cell destruction in type 1 diabetes is not fully understood. In early infancy there is an increased cell turnover. Recurrent exposure of tissue-specific antigens could lead to primary sensitization of immune cells in the draining lymph nodes of the pancreas. An initial immune injury to the beta cells can be inflicted by several cell, types, primarily macrophages and T cells. Subsequently, infiltrating macrophages transfer antigens exposed by apoptotic cells to the draining lymph nodes, where antigen presenting cells process and amplify a secondary immune reaction. Antigen presenting cells evolve as dual players in the activation and suppression of the autoimmune reaction in the draining lymph nodes. We propose a scenario where destructive insulitis is caused by recurrent exposure of specific antigens due to the physiological turnover of beta cells. This sensitization initiates the evolution of reactive clones that remain silent in the regional lymph nodes, where they succeed to evade regulatory clonal deletion. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:338 / 343
页数:6
相关论文
共 40 条
[1]   Checkpoints in the progression of autoimmune disease: Lessons from diabetes models [J].
Andre, I ;
Gonzalez, A ;
Wang, B ;
Katz, J ;
Benoist, C ;
Mathis, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2260-2263
[2]   Induction of tolerance using Fas ligand: a double-edged immunomodulator [J].
Askenasy, N ;
Yolcu, ES ;
Yaniv, I ;
Shirwan, H .
BLOOD, 2005, 105 (04) :1396-1404
[3]   Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice [J].
Baker, FJ ;
Lee, M ;
Chien, YH ;
Davis, MM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (14) :9374-9379
[4]   Gene- and cell-based therapeutics for type I diabetes mellitus [J].
Bottino, R ;
Lemarchand, P ;
Trucco, M ;
Giannoukakis, N .
GENE THERAPY, 2003, 10 (10) :875-889
[5]   ISLET-SPECIFIC T-CELL CLONES FROM NONOBESE DIABETIC MICE EXPRESS HETEROGENEOUS T-CELL RECEPTORS [J].
CANDEIAS, S ;
KATZ, J ;
BENOIST, C ;
MATHIS, D ;
HASKINS, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6167-6170
[6]   PREVENTION OF DIABETES IN NONOBESE DIABETIC MICE BY DENDRITIC CELL TRANSFER [J].
CLARESALZLER, MJ ;
BROOKS, J ;
CHAI, A ;
VANHERLE, K ;
ANDERSON, C .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :741-748
[7]  
COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.iy.10.040192.001411
[8]   Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation [J].
Dor, Y ;
Brown, J ;
Martinez, OI ;
Melton, DA .
NATURE, 2004, 429 (6987) :41-46
[9]   Immunotherapy of NOD mice with bone marrow-derived dendritic cells [J].
Feili-Hariri, M ;
Dong, X ;
Alber, SM ;
Watkins, SC ;
Salter, RD ;
Morel, PA .
DIABETES, 1999, 48 (12) :2300-2308
[10]   Antigen-specific induction of regulatory T cells for type 1 diabetes therapy [J].
Filippi, C ;
Bresson, D ;
von Herrath, M .
INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2005, 24 (5-6) :341-360